×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Mulroy Michael H.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
LCTXLineage Cell Therapeutics, Inc.Mulroy Michael H.DirectorMar 24, 2022Buy$1.407,0009,800258,555Mar 25, 2022, 04:15 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOMar 01, 2019Option Exercise$0.9576,58872,759273,622Mar 05, 2019, 04:31 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOAug 27, 2018Buy$1.593,1415,00097,604Aug 29, 2018, 08:02 AM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOJul 25, 2018Buy$1.692,9505,00094,463Jul 27, 2018, 04:00 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOJun 25, 2018Buy$1.633,0674,99991,513Jun 27, 2018, 07:03 AM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOMay 25, 2018Buy$1.593,1535,00088,446May 31, 2018, 05:00 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOApr 25, 2018Buy$1.333,7524,99085,293Apr 27, 2018, 04:33 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOMar 26, 2018Buy$1.762,8394,99781,541Mar 28, 2018, 05:00 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOMar 15, 2018Option Exercise$1.9528,35855,29878,702Mar 19, 2018, 07:03 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOFeb 26, 2018Buy$2.222,2555,00012,188Feb 28, 2018, 04:21 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOJan 25, 2018Buy$2.342,1345,0009,933Jan 26, 2018, 04:01 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEODec 26, 2017Buy$2.222,2474,9887,799Dec 28, 2017, 07:41 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEONov 27, 2017Buy$2.412,0765,0035,552Nov 29, 2017, 04:01 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOOct 25, 2017Buy$2.551,9394,9443,476Oct 27, 2017, 04:00 PM
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.President and CEOSep 25, 2017Buy$3.251,5374,9971,537Sep 27, 2017, 02:04 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.See RemarksAug 11, 2014Sale$92.3310,000923,34770,714Aug 13, 2014, 02:28 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.See RemarksJul 31, 2014Option Exercise$92.351,304120,42475,759Aug 04, 2014, 08:03 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.See RemarksJul 10, 2014Sale$52.5720,0001,051,31287,063Jul 14, 2014, 05:31 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.See RemarksJun 10, 2014Sale$51.4120,0001,028,14587,063Jun 12, 2014, 06:43 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.See RemarksMay 12, 2014Sale$51.1220,0001,022,30887,063May 14, 2014, 06:05 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.See RemarksApr 10, 2014Sale$49.6420,000992,80087,063Apr 14, 2014, 07:09 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.See RemarksMar 10, 2014Sale$39.5220,000790,39187,063Mar 12, 2014, 06:16 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.See RemarksFeb 24, 2014Option Exercise$79.4612,552997,38277,063Feb 26, 2014, 08:05 PM
QCORQUESTCOR PHARMACEUTICALS INCMulroy Michael H.Sr VP, CFO & General CounselMay 23, 2012Buy$40.001,00040,0002,117May 24, 2012, 09:01 AM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe